Production (Stage)
CureVac N.V.
CVAC
$5.54
-$0.03-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.44% | 274.42% | 416.71% | -6.41% | -24.38% |
| Total Depreciation and Amortization | -8.84% | -24.11% | -32.31% | -10.07% | -15.82% |
| Total Amortization of Deferred Charges | -- | -45.97% | -- | -- | -- |
| Total Other Non-Cash Items | -98.63% | -31.82% | 1,617.97% | -206.73% | 1,397.14% |
| Change in Net Operating Assets | 112.35% | -165.17% | -246.78% | -24.97% | 4.26% |
| Cash from Operations | 58.46% | 426.44% | 339.69% | -37.43% | 1.85% |
| Capital Expenditure | 90.75% | 79.59% | 73.14% | 76.22% | 60.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.84% | 92.47% | 99.16% | -30,780.28% | 89.42% |
| Cash from Investing | 90.27% | 79.83% | 77.92% | 47.89% | 60.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.63% | -7.29% | 8.44% | 0.47% | 3.25% |
| Issuance of Common Stock | -- | -- | -- | -38.57% | -99.96% |
| Repurchase of Common Stock | -- | 62.09% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -150.00% | 50.00% | -- | -- |
| Cash from Financing | -13.15% | 2.53% | -15.68% | -0.54% | -100.48% |
| Foreign Exchange rate Adjustments | -145.76% | 107.81% | -87.37% | 336.15% | 297.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.86% | 324.08% | 291.14% | -21.30% | -185.08% |